Literature DB >> 12096204

Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status.

M C Zoia1, A M D'Armini, M Beccaria, A Corsico, P Fulgoni, C Klersy, F Piovella, M Viganò, I Cerveri.   

Abstract

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) can be successfully treated surgically by pulmonary thromboendarterectomy (PTE) but there are few data on mid-term cardiopulmonary function, particularly on exertion, and clinical benefits following pulmonary PTE.
METHODS: A 2 year follow up study was undertaken of clinical status, haemodynamic and lung function indices, gas exchange, and exercise tolerance in 38 patients of mean (SD) age 50 (15) years who had undergone PTE.
RESULTS: In-hospital mortality was about 10%. Before PTE all the patients were severely impaired (NYHA classes III-IV). There was no time difference in the improvement in the parameters: nearly all the improvement in cardiac output, gas exchange, and clinical status was achieved in the first 3 months as a result of the relief of pulmonary obstruction. At 3 months the percentage of patients with normal cardiac output and PaO(2) and of those with reduced clinical impairment increased to 97%, 59%, and 87%, respectively, without any further change. Only mean pulmonary artery pressure (mPAP), carbon monoxide transfer factor (TLCO), and exercise tolerance improved gradually during the second year, probably due to the recovery of the damaged small vessels. TLCO was overestimated before PTE but afterwards the trend was similar to that of mPAP.
CONCLUSIONS: At mid term only a few patients did not have a satisfactory recovery because of lack of operative success, hypertension relapse, or the effect of preoperative hypertension on vessels in non-obstructed segments. Most of the patients, even the more compromised ones, had excellent long lasting results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096204      PMCID: PMC1746368          DOI: 10.1136/thorax.57.7.608

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

Review 1.  Surgery for chronic thromboembolic pulmonary hypertension.

Authors:  R S Hartz
Journal:  World J Surg       Date:  1999-11       Impact factor: 3.352

2.  Natural course of treated pulmonary embolism. Evaluation by perfusion lung scintigraphy, gas exchange, and chest roentgenogram.

Authors:  R Prediletto; P Paoletti; E Fornai; A Perissinotto; S Petruzzelli; B Formichi; S Ruschi; A Palla; A Giannella-Neto; C Giuntini
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

3.  Risk factors for pulmonary thromboendarterectomy.

Authors:  P O Daily; W P Dembitsky; S Iversen; K M Moser; W Auger
Journal:  J Thorac Cardiovasc Surg       Date:  1990-04       Impact factor: 5.209

4.  Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension.

Authors:  K S Kapitan; M Buchbinder; P D Wagner; K M Moser
Journal:  Am Rev Respir Dis       Date:  1989-05

Review 5.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

Authors:  P H Quanjer; G J Tammeling; J E Cotes; O F Pedersen; R Peslin; J C Yernault
Journal:  Eur Respir J Suppl       Date:  1993-03

Review 6.  Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis.

Authors:  P Egermayer; A J Peacock
Journal:  Eur Respir J       Date:  2000-03       Impact factor: 16.671

7.  Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period.

Authors:  S W Jamieson; W R Auger; P F Fedullo; R N Channick; J M Kriett; R Y Tarazi; K M Moser
Journal:  J Thorac Cardiovasc Surg       Date:  1993-07       Impact factor: 5.209

8.  Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; C M Bloor
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

9.  Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy.

Authors:  K S Kapitan; J L Clausen; K M Moser
Journal:  Chest       Date:  1990-07       Impact factor: 9.410

10.  Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group.

Authors:  R F Grossman; A Frost; N Zamel; G A Patterson; J D Cooper; P R Myron; C L Dear; J Maurer
Journal:  N Engl J Med       Date:  1990-03-15       Impact factor: 91.245

View more
  8 in total

1.  Pulmonary thromboendarterectomy almost 50 years after the first surgical attempts.

Authors:  I Cerveri; A M D'Armini; M Viganò
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

2.  Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.

Authors:  Athanasios Charalampopoulos; J Simon R Gibbs; Rachel J Davies; Wendy Gin-Sing; Kevin Murphy; Karen K Sheares; Joanna Pepke-Zaba; David P Jenkins; Luke S Howard
Journal:  J Appl Physiol (1985)       Date:  2016-07-14

3.  Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension.

Authors:  Amy L Firth; Weijuan Yao; Aiko Ogawa; Michael M Madani; Grace Y Lin; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2010-02-24       Impact factor: 4.249

4.  Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Authors:  Sanjay Mehta; Doug Helmersen; Steeve Provencher; Naushad Hirani; Fraser D Rubens; Marc De Perrot; Mark Blostein; Kim Boutet; George Chandy; Carole Dennie; John Granton; Paul Hernandez; Andrew M Hirsch; Karen Laframboise; Robert D Levy; Dale Lien; Simon Martel; Gerard Shoemaker; John Swiston; Justin Weinkauf
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

Review 5.  Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Liyan Zhang; Yuping Bai; Peijing Yan; Tingting He; Bin Liu; Shanlian Wu; Zhen Qian; Changtian Li; Yunshan Cao; Min Zhang
Journal:  Heart Fail Rev       Date:  2021-02-05       Impact factor: 4.214

6.  Factors predicting outcome after pulmonary endarterectomy.

Authors:  Cécile Tromeur; Xavier Jaïs; Olaf Mercier; Francis Couturaud; David Montani; Laurent Savale; Mitja Jevnikar; Jason Weatherald; Olivier Sitbon; Florence Parent; Dominique Fabre; Sacha Mussot; Philippe Dartevelle; Marc Humbert; Gérald Simonneau; Elie Fadel
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

7.  An Australian tertiary referral center experience of the management of chronic thromboembolic pulmonary hypertension.

Authors:  Videshinie A Maliyasena; Peter M A Hopkins; Bruce M Thomson; John Dunning; Douglas A Wall; Benjamin J Ng; Keith D McNeil; Daniel Mullany; Fiona D Kermeen
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

8.  Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Takayuki Jujo; Nobuhiro Tanabe; Seiichiro Sakao; Hatsue Ishibashi-Ueda; Keiichi Ishida; Akira Naito; Fumiaki Kato; Takao Takeuchi; Ayumi Sekine; Rintaro Nishimura; Toshihiko Sugiura; Ayako Shigeta; Masahisa Masuda; Koichiro Tatsumi
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.